Moreover, the fact that P2X7 receptor antagonists significantly decreased carbon tetrachloride exacerbation of liver injury in obesity paved the way for future investigations using the antagonists as potential therapeutic molecules in treating steatohepatitis in obesity in its early phase [61]. Here, P2RX7 is linked to obesity disorder.